Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function
Clinical trial NCT06145282 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06145282
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-28
- Primary completion
- 2025-10-27
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.